CMS has posted the FFY 2016 Drug
Utilization Review (DUR) Annual State Reports at https://www.medicaid.gov/medicaid/prescription-drugs/drug-utilization-review/annual-reports/index.html along with the State Comparison/Summary Report
for FFY 2016 at https://www.medicaid.gov/medicaid-chip-program-information/by-topics/prescription-drugs/downloads/2016-dur-summary-report.pdf.
To help address the opioid abuse
epidemic, please note that states have actively implemented several
management control measures such as: using quantity limits and days supply
limits for short-acting and long-acting opiates, applying statewide
prescription drug monitoring programs and utilizing morphine daily dose
alerts to prevent drug overdose.
If you have any questions
regarding DUR, please contact the CMS DUR mailbox at DURPolicy@cms.hhs.gov.
|
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Tuesday, November 7, 2017
FFY 2016 Drug Utilization Review (DUR) Annual State Reports
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment